As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

A study concluded that the use of over-the-counter pain relievers is more effective than opioids for pain management after ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Ashoka Buildcon soared 5.13% to Rs 292 after its wholly-owned subsidiary, Ashoka Bowaichandi Guskara Road, has signed concession agreement with the National Highways Authority of India for the ...

Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.

CVS Health CVS shareholders are experiencing a rough period as the stock continues to face significant downward pressure. Recent reports about the company's strategic restructuring plans have placed ...